Microbot Medical Stock Market Capitalization
| MBOT Stock | USD 2.39 0.03 1.24% |
Microbot Medical's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Microbot Stock price.
| Last Reported | Projected for Next Year | ||
| Market Cap | 15.1 M | 29.1 M |
Microbot | Market Capitalization | Build AI portfolio with Microbot Stock |
Microbot Medical Company Market Capitalization Analysis
Microbot Medical's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Microbot Medical Market Capitalization | 162.52 M |
Most of Microbot Medical's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Microbot Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Microbot Market Capitalization Driver Correlations
Understanding the fundamental principles of building solid financial models for Microbot Medical is extremely important. It helps to project a fair market value of Microbot Stock properly, considering its historical fundamentals such as Market Capitalization. Since Microbot Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Microbot Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Microbot Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Microbot Long Term Debt To Capitalization
Long Term Debt To Capitalization |
|
Based on the recorded statements, the market capitalization of Microbot Medical is about 162.52 M. This is 98.74% lower than that of the Health Care Equipment & Supplies sector and 98.04% lower than that of the Health Care industry. The market capitalization for all United States stocks is 99.15% higher than that of the company.
Microbot Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Microbot Medical's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Microbot Medical could also be used in its relative valuation, which is a method of valuing Microbot Medical by comparing valuation metrics of similar companies.Microbot Medical is currently under evaluation in market capitalization category among its peers.
Microbot Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Microbot Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Microbot Medical's managers, analysts, and investors.Environmental | Governance | Social |
Microbot Fundamentals
| Return On Equity | -0.7 | ||||
| Return On Asset | -0.42 | ||||
| Current Valuation | 134.83 M | ||||
| Shares Outstanding | 67.16 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 8.90 % | ||||
| Number Of Shares Shorted | 4.23 M | ||||
| Price To Earning | (3.42) X | ||||
| Price To Book | 5.51 X | ||||
| EBITDA | (11.35 M) | ||||
| Net Income | (11.44 M) | ||||
| Cash And Equivalents | 9.29 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 111 K | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 5.60 X | ||||
| Book Value Per Share | 0.80 X | ||||
| Cash Flow From Operations | (8.83 M) | ||||
| Short Ratio | 0.96 X | ||||
| Earnings Per Share | (0.58) X | ||||
| Target Price | 12.0 | ||||
| Number Of Employees | 20 | ||||
| Beta | 1.25 | ||||
| Market Capitalization | 162.52 M | ||||
| Total Asset | 6.03 M | ||||
| Retained Earnings | (90.94 M) | ||||
| Working Capital | 3.36 M | ||||
| Current Asset | 15.21 M | ||||
| Current Liabilities | 9.83 M | ||||
| Net Asset | 6.03 M |
About Microbot Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Microbot Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Microbot Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Microbot Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.